VOLUME 21 - NUMBER 3 / July - September (Original articles / Artículos originales)
Astor Aguirre-Acuña, Servicio de Oncología, Centro Cancerológico del Caribe, CECAC, Barranquilla, Atlántico, Colombia
Hernando Chacón-Chacón, Servicio de Oncología, Centro Cancerológico del Caribe, CECAC, Barranquilla, Atlántico, Colombia
Guadalupe Arnedo-Franco, Servicio de Oncología, Centro Cancerológico del Caribe, CECAC; Programa de Enfermería, Universidad Metropolitana; Barranquilla, Atlántico, Colombia
Milagro Siado-Figueroa, Servicio de Oncología, Centro Cancerológico del Caribe, CECAC, Barranquilla, Atlántico, Colombia
Adalgisa Alcocer-Olaciregui, Programa de Medicina, Universidad Libre, Barranquilla, Atlántico, Colombia
Rusvelt Vargas-Moranth, Grupo de Investigación GIES, Universidad de Cartagena; Departamento de Ciencias de la Salud, Universidad de la Costa. Barranquilla, Atlántico, Colombia
Background: Delays in time between diagnosis and treatment of breast cancer can affect survival. Objective: To determine survival according to the time between diagnosis and the start of treatment in women with breast cancer, which treated at a center in the city of Barranquilla. Material and methods: Retrospective study of 235 women with breast cancer in whom overall survival was evaluated. Kaplan–Meier and log-rank analysis were performed. Binary logistic regression was performed using SPSS, version 19. Results: Mean age was 55.3 years (± 12.2), mean time in care 99.9 days (± 132.3), and mean overall survival 69.3 months (95% CI: 63.4-75.3). Survival was lower with less chance: 60.9 months (95% CI: 54.3-67.6). Statistical significance was found for: age under 60 years, subsidized health regimen, and positive E/P recipients. Conclusions: Interventions are needed to reduce delays in starting treatment and improve survival in patients with breast cancer.
Keywords: Survival. Time. Breast cancer.
